Northern Technologies International Corporation (NASDAQ:NTIC) reported consolidated net sales of $23.309 million for its fiscal first quarter of 2026, a 9.2% increase from the prior-year period and marking a new quarterly record.
Eupraxia Pharmaceuticals (NASDAQ:EPRX) reported positive interim data from its ongoing Phase 1b/2a RESOLVE trial evaluating EP-104GI in patients with eosinophilic esophagitis.
RPM International (NYSE:RPM), a world leader in specialty coatings, sealants and building materials, reported record fiscal second-quarter sales of $1.91 billion for the period ended November 30, 2025, representing a 3.5% increase over the prior-year record.
Watertown, Massachusetts-based Acrivon Therapeutics (NASDAQ:ACRV) provided an interim clinical update across its precision oncology pipeline, highlighted by promising response rates for its lead candidate ACR-368 in an ongoing Phase 2b trial.
Invivyd (NASDAQ:IVVD) reported preliminary fourth-quarter net product revenue of $17.2 million for its COVID-19 antibody, PEMGARDA.
The figure marks a 25% increase over the same period last year and a 31% sequential jump from the third quarter.
Simply Good Foods (NASDAQ:SMPL) reported a 33.7% drop in net income to $25.3 million for the first quarter ended Nov. 29, 2025.
The Denver-based company was hit by a significant contraction in gross margins, which fell 590 basis points to 32.3%.
Lindsay Corporation (NYSE:LNN), a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, today reported its financial results for the first quarter of fiscal 2026, ended November 30, 2025.
Helen of Troy Limited (NASDAQ:HELE) reported third-quarter fiscal 2026 results that reflected ongoing headwinds in the consumer discretionary sector.
Commercial Metals Company (NYSE:CMC) reported solid financial performance for its fiscal first quarter of 2026, ended November 30, 2025, with net earnings of $177.3 million, or $1.58 per diluted share.
China is preparing to approve the import of Nvidia Corp.’s (NASDAQ:NVDA) H200 artificial intelligence chips for select commercial customers as soon as this quarter, according to people familiar with the matter.
NervGen Pharma Corp. (NASDAQ:NGEN) officially began trading on the Nasdaq Stock Market on January 8, marking a transition into a late-stage biopharmaceutical player.
Energy Fuels (NYSE:UUUU) released an updated Feasibility Study on Thursday for its 100%-owned heavy mineral sands project in Madagascar, signaling a major step toward transforming the company into a diversified critical minerals powerhouse.
